Integration of ultrasonography and circulating tumor DNA analysis enhances early detection of asymptomatic ovarian cancer

Key Points

Higher sensitivity and specificity of ctDNA compared to traditional ultrasound enhance early detection.
Combining ultrasound with ctDNA provides a more accurate diagnostic strategy for ovarian cancer.
The use of ctDNA as a biomarker may lead to noninvasive measures for diagnosing ovarian cancer.
Findings could contribute significantly to medical advancements in cancer detection methodologies.

Abstract

Our results suggest that ctDNA is a promising biomarker for the early detection of ovarian cancer, with higher sensitivity and specificity than ultrasound. The combination of ultrasound and ctDNA may provide a more accurate diagnostic strategy for the early detection of ovarian cancer. These findings may contribute to the development of novel noninvasive biomarkers for the early diagnosis of ovarian cancer.

Bookmark

View Full Paper

Cite This Study

Jiapaer et al. (Mon,) studied this question.

synapsesocial.com/papers/69a75d01c6e9836116a2660b https://doi.org/https://doi.org/10.5603/gpl.103762

Bookmark

View Full Paper